Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention

Inflammation and Atherosclerosis

Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724 · see citing works

Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>

Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499 · see citing works

Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,941 · see citing works

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391 · see citing works

Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States

Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J.-M., Lee, C. H., Oh, W. K., Kim, C. T., et al. (2006) · Diabetes · doi:10.2337/db06-0006 · Cited by 1,054 · see citing works

Efficacy of berberine in patients with type 2 diabetes mellitus

Yin, J., Xing, H., & Ye, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.013 · Cited by 801 · see citing works

Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor

Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 763 · see citing works

Novel Clinical Markers of Vascular Wall Inflammation

Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754 · see citing works

Atherothrombosis and High-Risk Plaque

Fuster, V., Moreno, P., Fayad, Z. A., Corti, R., & Badimón, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.074 · Cited by 736 · see citing works

Biomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus

Meigs, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1978 · Cited by 643 · see citing works

Changing concepts of atherogenesis

Libby, P. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00654.x · Cited by 629 · see citing works

The restenosis paradigm revisited: An alternative proposal for cellular mechanisms

Schwartz, R. S., Holmes, D. R., & Topol, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90389-5 · Cited by 562 · see citing works

Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention

Patti, G., Pasceri, V., Colonna, G., Miglionico, M., Fischetti, D., Sardella, G., Montinaro, A., & Sciascio, G. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.025 · Cited by 483 · see citing works

Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes

de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., Gibson, C. M., Antman, E. M., McCabe, C. H., Cannon, C. P., & D, E. B. M. (2003) · Circulation · doi:10.1161/01.cir.0000049742.68848.99 · Cited by 468 · see citing works

Berberine suppresses proinflammatory responses through AMPK activation in macrophages

Jeong, H. W., Hsu, K. C., Lee, J.-W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S., & Kim, J. B. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90599.2008 · Cited by 454 · see citing works

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression

Zhang, H., Wei, J., Xue, R., Wu, J.-D., Zhao, W., Wang, Z., Wang, S., Zhou, Z.-X., Song, D., Wang, Y., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.029 · Cited by 442 · see citing works

C-reactive protein and other inflammatory risk markers in acute coronary syndromes

Blake, G. J., & Ridker, P. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02953-4 · Cited by 367 · see citing works

Macrophages, Smooth Muscle Cells, and Tissue Factor in Unstable Angina

Moreno, P., Bernardi, V., López-Cuellar, J., Murcia, A. M., Palacios, I. F., Gold, H. K., Mehran, R., Sharma, S. K., Nemerson, Y., Fuster, V., et al. (1996) · Circulation · doi:10.1161/01.cir.94.12.3090 · Cited by 355 · see citing works

Functional SYNTAX Score for Risk Assessment in Multivessel Coronary Artery Disease

Nam, C., Mangiacapra, F., Entjes, R., Chung, I., Sels, J.-W. E. M., Tonino, P. A. L., Bruyne, B. D., Pijls, N. H. J., & Fearon, W. F. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.020 · Cited by 311 · see citing works

Metalloproteinases and Vulnerable Atherosclerotic Plaques

Newby, A. C. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.09.001 · Cited by 254 · see citing works

Inflammation and restenosis after percutaneous coronary interventions

Toutouzas, K. P. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.011 · Cited by 198 · see citing works

Berberine stimulates glucose transport through a mechanism distinct from insulin

Zhou, L., Yang, Y., Wang, X., Liu, S., Shang, W., Yuan, G., Li, F., Tang, J., Chen, M., & Chen, J. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.025 · Cited by 187 · see citing works

Inhibition of chemical carcinogenesis by berberine in rats and mice

Anis, K. V., Rajeshkumar, N. V., & Kuttan, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775901 · Cited by 159 · see citing works

Statin Therapy in Acute Coronary Syndromes

Sposito, A. C., & Chapman, M. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000032033.39301.6a · Cited by 159 · see citing works

Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study

Affuso, F., Ruvolo, A., Micillo, F., Saccà, L., & Fazio, S. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.05.017 · Cited by 135 · see citing works

Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism

Zhang, Q., Xiao, X., Feng, K., Wang, T., Li, W., Yuan, T., Sun, X., Sun, Q., Xiang, H., & Wang, H. (2010) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2011/924851 · Cited by 124 · see citing works

Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention

Patti, G., Chello, M., Pasceri, V., Colonna, D., Nusca, A., Miglionico, M., D’Ambrosio, A., Covino, E., & Sciascio, G. D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.061 · Cited by 123 · see citing works

Protective Effects of Berberine against Low-Density Lipoprotein (LDL) Oxidation and Oxidized LDL-Induced Cytotoxicity on Endothelial Cells

Hsieh, Y., Kuo, W., Lin, T.-W., Chang, H., Lin, T.-H., Chen, P., & Chu, S. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf071868c · Cited by 103 · see citing works

A REVIEW ON THE CHEMICAL AND PHARMACOLOGICAL ASPECTS OF GENUSBERBERIS

Ikram, M. (1975) · Planta Medica · doi:10.1055/s-0028-1097869 · Cited by 98 · see citing works

Berberine-induced LDLR up-regulation involves JNK pathway

Lee, S., Lim, H., Park, J., Lee, K., Jang, Y., & Park, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.060 · Cited by 94 · see citing works

Berberine inhibits the expression of TNFα, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARγ pathway

Chen, F. L., Yang, Z.-J., Liu, Y., Li, L. X., Liang, W. C., Wang, X. C., Zhou, W. B., Yang, Y., & Hu, R. (2008) · Endocrine · doi:10.1007/s12020-008-9089-3 · Cited by 91 · see citing works

Berberine – a novel approach to cholesterol lowering

Doggrell, S. A. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.683 · Cited by 72 · see citing works

Inflammation and Coronary Artery Disease

Ikeda, U. (2003) · Current Vascular Pharmacology · doi:10.2174/1570161033386727 · Cited by 71 · see citing works

Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages

Huang, Z., Wang, L., Meng, S., Wang, Y., Chen, T., & Wang, C. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.06.023 · Cited by 65 · see citing works

Adjunctive Pharmacotherapy before Percutaneous Coronary Intervention in Non-ST-Elevation Acute Coronary Syndromes: The Role of Modulating Inflammation

Kereiakes, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000086951.09881.51 · Cited by 52 · see citing works

Berberine-induced decline in circulating CD31+/CD42− microparticles is associated with improvement of endothelial function in humans

Wang, J.-M., Yang, Z., Xu, M.-G., Chen, L., Wang, Y., Su, C., & Tao, J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.037 · Cited by 45 · see citing works

Effect of Apitherapy in Piglets with Preweaning Diarrhea

Choi, S. H., Cho, S. K., Kang, S. S., Bae, C. S., Bai, Y. H., Lee, S. H., & Pak, S. C. (2003) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x03001004 · Cited by 33 · see citing works

The coronary artery response to implantation of a balloon-expandable flexible stent in the aspirin- and non-aspirin-treated swine model

Rodgers, G. P., Minor, S. T., Robinson, K. A., Cromeens, D. M., Stephens, L. C., Woolbert, S., Guyton, J. R., Wright, K. C., Siegel, R. J., Roubin, G. S., et al. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90506-d · Cited by 26 · see citing works

Biochemical pathways in the antiatherosclerotic effect of berberine

Guo, Y., Wang, Q., Fang-ming, L. I., Jiang, X. M., Zuo, Y., & Wang, L. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200807010-00009 · Cited by 20 · see citing works

Meta‐analysis of the role of high‐dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease

Hao, P., Chen, Y., Wang, J., Ji, W., Li, X., Liu, X., Wang, X., & Zhang, Y. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05339.x · Cited by 19 · see citing works

An important role for VCAM-1, but not for ICAM-1 in restenosis following coronary stent implantation

Bayata, S., Arıkan, E., Yeşil, M., Postacı, N., Tas, A., & Köseoğlu, M. (2010) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2010.137 · Cited by 16 · see citing works

Systemic inflammatory markers in acute coronary syndrome: association with cardiovascular risk factors and effect of early lipid lowering

Meredith, I. T., Plunkett, J. C., Worthley, S. G., Hope, S. A., & Cameron, J. D. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200510000-00001 · Cited by 15 · see citing works

Short‐Term Treatment with High‐Dose Atorvastatin Reduces LDL Cholesterol but Shows no Anti‐Inflammatory Effects in Normolipidemic Subjects with Normal CRP Levels

Millar, J. S., Ky, B., Wolfe, M. L., Pruscino, L., Baer, A. L., & Rader, D. J. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00211.x · Cited by 15 · see citing works

Inflammatory Protein Levels and Depression Screening After Coronary Stenting Predict Major Adverse Coronary Events

Frazier, L. Q., Vaughn, W. K., Willerson, J. T., Ballantyne, C. M., & Boerwinkle, E. (2009) · Biological Research For Nursing · doi:10.1177/1099800409332801 · Cited by 15 · see citing works

Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia

Dimitrow, P. P., & Jawień, M. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70390-x · Cited by 14 · see citing works

Impact of lipid lowering therapy on liver function

Paragh, G., & Fülöp, P. (2009) · Orvosi Hetilap · doi:10.1556/oh.2009.28629 · Cited by 5 · see citing works

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics

Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465 · see citing works

Berberine and barberry ( Berberis vulgaris ): A clinical review

Imenshahidi, M., & Hosseinzadeh, H. (2019) · Phytotherapy Research · doi:10.1002/ptr.6252 · Cited by 370 · see citing works

Berberis Vulgaris and Berberine: An Update Review

Imenshahidi, M., & Hosseinzadeh, H. (2016) · Phytotherapy Research · doi:10.1002/ptr.5693 · Cited by 363 · see citing works

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O. S., Djuric, D. M., Владиславович, Е. М., Fras, Z., Katsiki, N., Langlois, M. R., Latkovskis, G., et al. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux047 · Cited by 298 · see citing works

Berberine and Its Role in Chronic Disease

Cicero, A. F. G., & Baggioni, A. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-41334-1_2 · Cited by 285 · see citing works

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281 · see citing works

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.040 · Cited by 272 · see citing works

Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine

Singh, S., Pathak, N., Fatima, E., & Negi, A. S. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113839 · Cited by 221 · see citing works

Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis

Domitrović, R., Cvijanović, O., Pugel, E. P., Škoda, M., Mikelić, L., & Crnčević-Orlić, Ž. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.09.003 · Cited by 191 · see citing works

Pharmacological effects of berberine and its derivatives: a patent update

Jin, Y., Khadka, D. B., & Cho, W. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1118060 · Cited by 174 · see citing works

Role of berberine in Alzheimer’s disease

Cai, Z., Wang, C., & Yang, W. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114846 · Cited by 160 · see citing works

Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach

Cicero, A. F. G., Fogacci, F., & Colletti, A. (2017) · Food & Function · doi:10.1039/c7fo00178a · Cited by 142 · see citing works

Learning from berberine: Treating chronic diseases through multiple targets

Yao, J., Kong, W., & Jiang, J. (2013) · Science China Life Sciences · doi:10.1007/s11427-013-4568-z · Cited by 118 · see citing works

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Cicero, A. F. G., Fogacci, F., Stoian, A. P., Vrablik, M., Al Rasadi, K., Banach, M., Toth, P. P., & Rizzo, M. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00955-y · Cited by 110 · see citing works

Berberine suppresses LPS‐induced inflammation through modulating Sirt1/NF‐&kgr;B signaling pathway in RAW264.7 cells

Zhang, H., Shan, Y., Wu, Y., Xu, C., Yu, X.-Z., Zhao, J., Yan, J., & Shang, W.-B. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.032 · Cited by 106 · see citing works

Berberine Hydrochloride Prevents Postsurgery Intestinal Adhesion and Inflammation in Rats

Zhang, Y., Li, X., Zhang, Q.-W., Li, J.-M., Ju, J., Du, N., Liu, X., Chen, X., Cheng, F.-R., Yang, L., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.212795 · Cited by 88 · see citing works

Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders

Caliceti, C., Franco, P., Spinozzi, S., Roda, A., & Cicero, A. F. G. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160411143314 · Cited by 91 · see citing works

Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders

Kong, W., Vernieri, C., Foiani, M., & Jiang, J. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107496 · Cited by 88 · see citing works

Berberine alleviates oxidized low‐density lipoprotein‐induced macrophage activation by downregulating galectin‐3 via the NF‐κB and AMPK signaling pathways

Pei, C., Zhang, Y., Wang, P., Zhang, B., Fang, L., Liu, B., & Meng, S. (2019) · Phytotherapy Research · doi:10.1002/ptr.6217 · Cited by 80 · see citing works

Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease

Singh, A. K., Singh, S. K., Nandi, M. K., Mishra, G., Maurya, A., Rai, A., Rai, G. K., Awasthi, R., Sharma, B., & Kulkarni, G. T. (2019) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524919666190820160053 · Cited by 79 · see citing works

Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases

Guo, H., Feng, C., Zhang, W., Luo, Z., Zhang, H., Zhang, T., Ma, C., Zhan, Y., Li, R. P., Wu, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09852-0 · Cited by 75 · see citing works

Herbal drugs against cardiovascular disease: traditional medicine and modern development.

Li, L., Zhou, X.-W., Li, N., Sun, M., Lv, J., & Xu, Z.-C. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.04.009 · Cited by 60 · see citing works

Berberine Ameliorates Diabetic Neuropathy: TRPV1 Modulation by PKC Pathway

Zan, Y., Kuai, C.-X., Qiu, Z., & Huang, F. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500926 · Cited by 71 · see citing works

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

Rizzo, M., Colletti, A., Penson, P. E., Katsiki, N., Mikhailidis, D. P., Toth, P. P., Gouni‐Berthold, I., Mancini, J., MARAIS, D. P., Moriarty, P. M., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106679 · Cited by 69 · see citing works

Recent Trends in Pharmacological Activity of Alkaloids in Animal Colitis: Potential Use for Inflammatory Bowel Disease

de Almeida, A. C. A., de‐Faria, F. M., Dunder, R. J., Manzo, L. P., Souza‐Brito, A. R. M., & Luiz-Ferreira, Â. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8528210 · Cited by 59 · see citing works

Effects of Berberine on Atherosclerosis

Rui, R., Yang, H., Liu, Y., Zhou, Y., Xu, X., Li, C., & Liu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.764175 · Cited by 57 · see citing works

A review on pain‐relieving activity of berberine

Hashemzaei, M., & Rezaee, R. (2020) · Phytotherapy Research · doi:10.1002/ptr.6984 · Cited by 56 · see citing works

Berberine Attenuates Ischemia-Reperfusion Injury Via Regulation of Adenosine-5′-monophosphate Kinase Activity in Both Non-ischemic and Ischemic Areas of the Rat Heart

Chang, W., Zhang, M., Li, J., Meng, Z., Xiao, D., Wei, S., Chen, L., Wang, C., & Hatch, G. M. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6422-0 · Cited by 54 · see citing works

Berberine Ameliorates Cold and Mechanical Allodynia in a Rat Model of Diabetic Neuropathy

Kim, S., & Kim, H. J. (2013) · Journal of Medicinal Food · doi:10.1089/jmf.2012.2648 · Cited by 48 · see citing works

Berberine inhibits proliferation and apoptosis of vascular smooth muscle cells induced by mechanical stretch via the PDI/ERS and MAPK pathways

Wang, L., Lie, D., Lin, N., Shi, Y., Chen, J., Zhou, Y., Chen, D., Liu, S., & Li, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118253 · Cited by 48 · see citing works

The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials

Asbaghi, O., Ghanbari, N., shekari, M., Reiner, Ž., Amirani, E., Hallajzadeh, J., Mirsafaei, L., & Asemi, Z. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.04.010 · Cited by 47 · see citing works

Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats

Guo, Z., Sun, H., Zhang, H., & Zhang, Y. (2015) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2014.972560 · Cited by 44 · see citing works

The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis

Cao, R. Y., Zhang, Y., Feng, Z., Liu, S., Liu, Y., Zheng, H., & Yang, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.764994 · Cited by 43 · see citing works

A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention

Bellavite, P., Fazio, S., & Affuso, F. (2023) · Molecules · doi:10.3390/molecules28114491 · Cited by 46 · see citing works

Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE−/− mice

Chen, J., Cao, J., Lu, F. Y., Liu, B., Zhou, Q., Sun, Y., Wang, Y., Li, Y., & Meng, S. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0326-7 · Cited by 42 · see citing works

Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments

Sajeev, A., Sailo, B., Unnikrishnan, J., Talukdar, A., Alqahtani, M. S., Abbas, M. A. E., Alqahtani, A., Sethi, G., & Kunnumakkara, A. B. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217019 · Cited by 40 · see citing works

Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial

Pirro, M., Mannarino, M. R., Ministrini, S., Fallarino, F., Lupattelli, G., Bianconi, V., Bagaglia, F., & Mannarino, E. (2016) · Scientific Reports · doi:10.1038/srep23587 · Cited by 39 · see citing works

Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk

Bianconi, V., Mannarino, M. R., Sahebkar, A., Cosentino, T., & Pirro, M. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0994-7 · Cited by 39 · see citing works

Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin

Caliceti, C., Rizzo, P., Ferrari, R., Fortini, F., Aquila, G., Leoncini, E., Zambonin, L., Rizzo, B., Calabria, D., Simoni, P., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.002 · Cited by 36 · see citing works

Statins: Neurobiological underpinnings and mechanisms in mood disorders

Walker, A. J., Kim, Y., Borissiouk, I., Rehder, R., Dodd, S., Morris, G., Nierenberg, A. A., Maes, M., Fernandes, B. S., Dean, O. M., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.012 · Cited by 33 · see citing works

Efficacy and safety of berberine for several cardiovascular diseases: a systematic review and meta-analysis of randomized controlled trials

Yang, L., Zhu, W., Zhang, X., Zhou, X., Wu, W., & Shen, T. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154716 · Cited by 34 · see citing works

Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine

Wang, S., Zhang, X., Cai, B., & Chen, Q. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200910105612 · Cited by 33 · see citing works

Berberine on the prevention and management of cardiometabolic disease: clinical applications and mechanisms of action

Cao, R. Y., Zheng, Y., Zhang, Y., Jiang, L., Li, Q., Sun, W., Gu, W., Cao, W., Zhou, L., Zheng, H., et al. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500762 · Cited by 31 · see citing works

Berberine inhibits the ischemia‑reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3‑kinase/RAC‑α serine/threonine‑protein kinase and nuclear factor-κB signaling pathways

Wang, L., Ma, H., Xue, Y., Shi, H., Ma, T., & Cui, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5575 · Cited by 30 · see citing works

Berberine Improved Aldo-Induced Podocyte Injury via Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress Pathways both In Vivo and In Vitro

Wang, B., Xu, X., He, X., Wang, Z., & Yang, M. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445618 · Cited by 29 · see citing works

Potential Benefits of Berberine in the Management of Perimenopausal Syndrome

Caliceti, C., Rizzo, P., & Cicero, A. F. G. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/723093 · Cited by 29 · see citing works

Food and plant bioactives for reducing cardiometabolic disease: How does the evidence stack up?

Cicero, A. F. G., & Colletti, A. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.04.001 · Cited by 29 · see citing works

The effects of berberine supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis

Zamani, M., Zarei, M., Nikbaf-Shandiz, M., Hosseini, S., Shiraseb, F., & Asbaghi, O. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1013055 · Cited by 28 · see citing works

Hypertriglyceridemia Therapy: Past, Present and Future Perspectives

Canfora, I., & Pierno, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179727 · Cited by 27 · see citing works

Nutraceutical combination (red yeast rice, berberine and policosanols) improves aortic stiffness in low-moderate risk hypercholesterolemic patients

Pirro, M., Lupattelli, G., Giorno, R. D., Schillaci, G., Berisha, S., Mannarino, M. R., Bagaglia, F., Melis, F., & Mannarino, E. (2013) · PharmaNutrition · doi:10.1016/j.phanu.2013.02.003 · Cited by 26 · see citing works

Therapeutic potential of targeting intestinal bitter taste receptors in diabetes associated with dyslipidemia

Chou, W.-L. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105693 · Cited by 29 · see citing works

Berberine inhibits tumor necrosis factor-α-induced expression of inflammatory molecules and activation of nuclear factor-κB via the activation of AMPK in vascular endothelial cells

Liu, S.-J., YIN, C.-X., Ding, M., WANG, Y., & WANG, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4061 · Cited by 23 · see citing works

A narrative review of plant and herbal medicines for delaying diabetic atherosclerosis: an update and future perspectives

Wang, Z.-C., Machuki, J. O., Li, M.-Z., Li, K., & Sun, H. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204142 · Cited by 21 · see citing works

Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia

Li, M., Qiu, Y., Zhang, J., Zhang, Y., Liu, Y., Zhao, Y., Jia, Q., Fan, X., & Li, J. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01359-4 · Cited by 21 · see citing works

Promising natural products against SARS‐CoV ‐2: Structure, function, and clinical trials

Zhao, Y., Deng, S., Bai, Y., Guo, J., Kai, G., Huang, X., & Jia, X. (2022) · Phytotherapy Research · doi:10.1002/ptr.7580 · Cited by 20 · see citing works

Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease

Coppinger, C., Pomales, B., Movahed, M. R., Marefat, M. M., & Hashemzadeh, M. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328250471231222094648 · Cited by 21 · see citing works

Berberine behind the thriller of marked symptomatic bradycardia

Cannillo, M. (2013) · World Journal of Cardiology · doi:10.4330/wjc.v5.i7.261 · Cited by 21 · see citing works

Lipid-lowering nutraceuticals update on scientific evidence

Derosa, G., Colletti, A., Maffioli, P., D’Angelo, A., Lupi, A., Zito, G., Mureddu, G. F., Raddino, R., Fedele, F., & Cicero, A. F. G. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000970 · Cited by 20 · see citing works

An update on the safety of nutraceuticals and effects on lipid parameters

Cicero, A. F. G., & Colletti, A. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1429404 · Cited by 20 · see citing works

Cytokine storm-calming property of the isoquinoline alkaloids in Coptis chinensis Franch

Lan, Y., Wang, H., Wu, J., & Meng, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.973587 · Cited by 19 · see citing works

Impacts of berberine on oxidized LDL-induced proliferation of human umbilical vein endothelial cells.

Xu, R., Sun, X., Ma, C., Yao, Y., Li, X., Guo, Y., Zhang, Y., Li, S., & Li, J. (2017) · PubMed Central · Cited by 19 · see citing works

Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Yanuck, S. F., Pizzorno, J. E., Messier, H., & Fitzgerald, K. N. (2020) · PubMed Central · Cited by 18 · see citing works

Berberine: Is it a Promising Agent for Mental Disorders Treatment?

Shayganfard, M. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220509213122 · Cited by 18 · see citing works

Berberine inhibits low shear stress-induced glycocalyx degradation via modulating AMPK and p47phox/Hyal2 signal pathway

Yang, H., Zhu, L., Gu, Y., Kong, X., liu, Y., Chen, M., Xie, X., Luo, J., & Chen, S. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172413 · Cited by 18 · see citing works

Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects

Li, J., Liu, H.-H., Wu, N., Yeo, K. K., Tan, K. C. B., Ako, J., Krittayaphong, R., Tan, R., Aylward, P. E., Baek, S. H., et al. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1802426 · Cited by 19 · see citing works

Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials

Beba, M., Djafarian, K., & Shab-Bidar, S. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.08.002 · Cited by 15 · see citing works

Phytochemicals as potential IKK-β inhibitor for the treatment of cardiovascular diseases in plant preservation: terpenoids, alkaloids, and quinones

Hua, F., Shi, L., & Zhou, P. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00640-2 · Cited by 15 · see citing works

The Hidden Treasure in Europe?s Garden Plants: Case Examples; Berberis darwinni and Berginia cordifolia

Habtemariam, S. (2012) · Medicinal & Aromatic Plants · doi:10.4172/2167-0412.1000130 · Cited by 15 · see citing works

Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias

Scognamiglio, M., Costa, D., Sorriento, A., & Claudio Napoli, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130101108 · Cited by 15 · see citing works

Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis

Chen, C., Lin, Q., Zhu, X., Xia, J., Mao, T., Chi, T., Wan, J., Lu, J., Li, Y., Cui, J., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.646306 · Cited by 14 · see citing works

Can Berberine Serve as a New Therapy for Parkinson’s Disease?

Dadgostar, E., Moghanlou, M., Parvaresh, M., Mohammadi, S., Khandan, M., Aschner, M., Mirzaei, H., & Tamtaji, O. R. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00526-2 · Cited by 13 · see citing works

The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials

Tehrani, S. D., Shojaei, M., Bagherniya, M., Pirro, M., & Sahebkar, A. (2023) · Phytotherapy Research · doi:10.1002/ptr.7763 · Cited by 13 · see citing works

Plant protoberberine alkaloids: structural diversity, biosynthesis, synthesis, biological activity, structure-activity relationships and clinical applications of berberine

Jiang, W., Zhang, W., Jing, C.-X., Zhou, H., Zhang, Z.-J., Wang, R., & Liu, Y. (2025) · Phytochemistry · doi:10.1016/j.phytochem.2025.114690 · Cited by 12 · see citing works

Current research progress in identifying the mechanism of berberine in pain regulation

Han, S., Yan, R., Guan, S., Fan, W.-J., Chu, H., & Liang, Y. (2021) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100019 · Cited by 11 · see citing works

The Ameliorative Effect of Berberine on Vascular Calcification by Inhibiting Endoplasmic Reticulum Stress

Li, L., Zheng, G., Cao, C., Cao, W., Yan, H., Chen, S., Ding, C., Gan, D., Yuan, J., Che, D., et al. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001303 · Cited by 10 · see citing works

Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy

Colletti, A., Fratter, A., Pellizzato, M., & Cravotto, G. (2022) · Nutrients · doi:10.3390/nu14224769 · Cited by 10 · see citing works

Berberis vulgaris L. Root Extract as a Multi-Target Chemopreventive Agent against Colon Cancer Causing Apoptosis in Human Colon Adenocarcinoma Cell Lines

Och, A., Lemieszek, M. K., Cieśla, M., Jędrejek, D., Kozłowska, A., Pawelec, S., & Nowak, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094786 · Cited by 9 · see citing works

Resetting the aging clock through epigenetic reprogramming: Insights from natural products

Liu, X., Feng, J. H., Guo, M., Chen, C., Zhao, T., Sun, X., & Zhang, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108850 · Cited by 9 · see citing works

Barberry (Berberis vulgaris)—Traditional and Contemporary Use

Och, A., & Nowak, R. (2021) · Sustainable development and biodiversity · doi:10.1007/978-3-030-74779-4_24 · Cited by 9 · see citing works

Multitarget natural compounds taming NETosis: A translational strategy for cancer and inflammatory diseases

Jia, W., Zhang, J., Shang, Y., & Liu, S. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218103 · Cited by 7 · see citing works

Hypolipaemic nutraceutics: red yeast rice and Armolipid, berberine and bergamot

Kłosiewicz−Latoszek, L., Cybulska, B., Stos, K., & Tyszko, P. Z. (2020) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/130629 · Cited by 7 · see citing works

Iranian traditional medicinal plants for management of chronic heart failure: A review

Keihanian, F., Moohebati, M., Saeidinia, A., & Mohajeri, S. A. (2023) · Medicine · doi:10.1097/md.0000000000033636 · Cited by 7 · see citing works

Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction?

Cicero, A. F. G., Tartagni, E., & Borghi, C. (2012) · Clinical Lipidology · doi:10.2217/clp.12.55 · Cited by 7 · see citing works

Exploring the Complementary Role of Traditional Chinese Medicine in Enhancing Percutaneous Coronary Intervention Outcomes: Mechanisms, Benefits, and Future Research Directions

Zheng, S., Guo, J., & Wang, Q. (2025) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s511630 · Cited by 6 · see citing works

The role of berberine in polycystic ovary syndrome — a summary of knowledge

Jurgiel, J., Graniak, A., Opyd, P., Zawodny, T., & Lis, M. (2023) · Ginekologia Polska · doi:10.5603/gpl.95138 · Cited by 6 · see citing works

Myelosuppression and Nephrotoxicity Induced by Cisplatin in Female Rats: The Role of Berberine Nanoparticles

Mohamed, N. A. (2018) · JOURNAL OF ADVANCES IN BIOLOGY · doi:10.24297/jab.v11i1.7556 · Cited by 4 · see citing works

Anti-allergic drug discovery in China for eczema: current methods and future strategies

Hon, K. E., Lau, C. B., Hui, C. L., & Leung, P. C. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.795539 · Cited by 4 · see citing works

Bitter taste receptor-mediated regulation of glycolipid metabolism and natural product-based targeted therapies: A review

Bao, T., Xue, C., Wang, Y., Chen, J., Dong, L., Yang, Y., Shi, J., Wang, Z., Tang, R., Wang, X., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145759 · Cited by 4 · see citing works

Anti‐inflammatory treatment in patients after percutaneous coronary intervention: another potential use for berberine?

Fan, F., & Dart, A. M. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05695.x · Cited by 3 · see citing works

Natural products in regeneration

Wilson, R. B., Lee, J. J., Pickering, J. G., & Borradaile, N. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00027-5 · Cited by 3 · see citing works

Innovative drug discovery for cardiovascular metabolic inflammation diseases

Zhao, Y., Wang, Q., Ma, Y., Wang, J., Han, Y., & Ji, Y. H. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70131 · Cited by 2 · see citing works

Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms.

Tian, K.-L., Tian, R., Qin, L., Liu, H., Malik, F., Wei, P., Zou, J., Li, K., Hou, H., Sun, K., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157176 · Cited by 2 · see citing works

Natural products targeting the gut-brain axis for the treatment of post-cardiac procedures anxiety or depression

Ning, B., Wei, Y., Luo, C., Yang, L., Zheng, Z., Fang, P., Ge, T., Wang, C., Hu, J., Zhao, Q., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158061 · Cited by 2 · see citing works

Berberine Improves Kidney Injury Following Renal Ischemia Reperfusion in Rats

Gholampour, F., Moghadam, S. M. F., & Owji, S. M. (2014) · International Journal of Zoological Research · doi:10.3923/ijzr.2015.9.18 · Cited by 2 · see citing works

Food and Plant Bioactives for Reducing Cardiovascular Disease Risk

Cicero, A. F. G., & Colletti, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-57469-7_7 · Cited by 1 · see citing works

Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular DiseasePreprint

Hashemzadeh, M. (2023) · doi:10.22541/au.170107961.10347438/v1

Natural Compounds Targeting Profibrotic Signaling Pathways in Myocardial Fibrosis: Signaling Network Regulation and Therapeutic Potential

Li, Y., Zhang, L., Li, M., Liu, X., Zhenzhen, L., Wei, W., & Lei, C. (2026) · Natural Product Communications · doi:10.1177/1934578x261454083

A Look At Non-Statin Lipid-Lowering Pharmacological Therapy

Vedernikov, A., Михайлович, М. Е., Vedernikova, S. A., & Vyalkina, Y. A. (2026) · The Russian Archives of Internal Medicine · doi:10.33396/2226-6704-2026-16-5-325-335

Change of inflammation factors in patients with acute coronary syndrome and its intervention with benazepril

Su, P. (2012) · Zhonghua laonian xin-nao-xueguanbing zazhi

Influence of Detoxificating and Activating Blood Herbal Medicine on Inflammatory Factors of the Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention

Wang, Y. (2011)

Adjunctive Pharmacotherapy before Percutaneous Coronary Intervention in Non-ST-Elevation Acute Coronary Syndromes: The Role of Modulating Inflammation

Kereiakes, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000086951.09881.51 · Cited by 52 · see citing works

Observe the effect of tirofiban on serum inflammatory variation with acute coronary syndrome after percutaneous coronary intervention

Liu, X. (2011) · China Practical Medicine

Influence of atorvastatin on effect and inflammatory factors after percutaneous transluminal coronary intervention in patients with acute coronary syndrome

Bi, X. (2015) · Journal of Clinical Medicine in Practice